BACE1 and Alzheimer disease: Throughout this review, numerous 1,3,5-triazine-based molecules have been depicted as displaying remarkable efficacy in targeting one or more hallmarks of AD, particularly by inhibiting AChE, BACE-1 or even modulating Aβ-aggregation.